Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know

Adma Biologics (ADMA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • 10 hours ago

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks Investment Research • 9 hours ago

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

RAMSEY, N.J. and BOCA RATON, Fla.

GlobeNewsWire • Oct 28, 2026

Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing

Adma Biologics (ADMA) closed the most recent trading day at $11.24, moving +1.49% from the previous trading session.

Zacks Investment Research • Oct 20, 2026

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Optimized Process Demonstrated Effective Removal of Procoagulant Impurities While Maintaining Immunoglobulin Quality and Increasing IgG Yield

GlobeNewsWire • Oct 15, 2026

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • Oct 12, 2026

ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Adma Biologics (ADMA). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research • Oct 8, 2026

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

In the latest trading session, Adma Biologics (ADMA) closed at $10.33, marking a +1.87% move from the previous day.

Zacks Investment Research • Oct 8, 2026

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market

In the most recent trading session, Adma Biologics (ADMA) closed at $10, indicating a -1.24% shift from the previous trading day.

Zacks Investment Research • Sep 29, 2026

Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • Sep 24, 2026